NCT04063397Completed
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
Source: ClinicalTrials.gov · Last updated 10 Jan 2024
Brief summary (registry, in English)
The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to evaluate several biomarkers to determine if there is a correlation with short and medium-term cardiovascular risk. This opens the door to earlier detection, treatment and improved cardiovascular outcomes.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 27 (actual)
- First submitted
- 19 Aug 2019
- Start date
- 19 Aug 2019
- Primary completion date
- 30 Jan 2023
- Lead sponsor
- Ohio State University
- NCT number
- NCT04063397
What you commit to
- Study type: Observational
- Participants enrolled: 27
- From 19 Aug 2019 to the primary completion date, 30 Jan 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of medical problems that may contribute to cardiac dysfunction, including but not limited to chronic hypertension, poorly controlled hyperthyroidism and diabetes mellitus.
Lab values
- History of chronic hypertension or cardiac disease including but not limited to history of heart arrhythmias, congenital heart disease, and use of any cardiac medication (such as beta blockers, ACE inhibitors, calcium channel blockers) prior to pregnancy.
Other
- Multiple gestation
Who the study is looking for
- Females older than 18 years of age
- Singleton pregnancy
- The patient is physically and mentally able to understand the informed consent and is willing to participate in this study
- Able to speak English
- Must meet one of the population categories, until each group has reached 20 subjects
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Ohio State University Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.